Sort   by:  
 Page size 
UnknownALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

Aims

This post hoc analysis evaluated albumin/bilirubin (ALBI) score, an objective measure of liver function, in patients receiving pembrolizumab plus best supportive care (BSC) compared with placebo plus BSC in the KEYNOTE-240 study.

Methods

Patients with confirmed hepatocellular car...
S-EPMC8488519 | biostudies-literature
Sort   by:  
 Page size